Shanghai Wanye Enterprises Co Ltd
SSE:600641
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its Industry Average (10.9), the stock would be worth ¥-38.92 (241% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -7.7 | ¥27.62 |
0%
|
| Industry Average | 10.9 | ¥-38.92 |
-241%
|
| Country Average | 26.4 | ¥-94.31 |
-441%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
S
|
Shanghai Wanye Enterprises Co Ltd
SSE:600641
|
25.7B CNY | -7.7 | -203 | |
| HK |
|
China Resources Land Ltd
HKEX:1109
|
231.8B HKD | 3.5 | 7.8 | |
| VN |
V
|
Vinhomes JSC
VN:VHM
|
599.7T VND | 8.1 | 14.3 | |
| HK |
|
CK Asset Holdings Ltd
HKEX:1113
|
171B HKD | 4.9 | 15.7 | |
| HK |
|
Henderson Land Development Co Ltd
HKEX:12
|
149B HKD | 10.5 | 26.4 | |
| HK |
|
China Overseas Land & Investment Ltd
HKEX:688
|
145.3B HKD | 11.8 | 10.2 | |
| HK |
|
Sino Land Co Ltd
HKEX:83
|
118.5B HKD | 29.4 | 31.7 | |
| CN |
|
China Merchants Shekou Industrial Zone Holdings Co Ltd
SZSE:001979
|
78.4B CNY | 14.3 | 76.6 | |
| CN |
|
Poly Developments and Holdings Group Co Ltd
SSE:600048
|
72.9B CNY | -40.6 | 1 402.9 | |
| IN |
|
Macrotech Developers Ltd
NSE:LODHA
|
896.9B INR | 31.9 | 26.7 | |
| CN |
|
Longfor Group Holdings Ltd
HKEX:960
|
56.5B HKD | 3.2 | 48.8 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 13.7 |
| Median | 26.4 |
| 70th Percentile | 52.8 |
| Max | 2 279 450.9 |
Other Multiples
Shanghai Wanye Enterprises Co Ltd
Glance View
Shanghai Wanye Enterprises Co Ltd has traversed an intriguing journey from its origins, evolving into a dynamic player in several sectors. Rooted in the bustling metropolis of Shanghai, the company navigates multiple industries with a focus on real estate, biotechnology, and high-tech investments. Over the years, Wanye has astutely recognized the potential in blending traditional real estate ventures with new-age biotech innovations. Its real estate arm concentrates primarily on the development and management of commercial and residential properties, leveraging its deep understanding of urban landscapes to maximize asset value. Meanwhile, its interest in biotechnology represents a strategic pivot towards high-growth sectors, signifying an alignment with global trends in health and science innovations. Money-making for Wanye Enterprises involves a sophisticated balance of developing high-demand real estate projects and acquiring stakes in promising biotech start-ups and technological ventures. This dual approach not only diversifies its revenue streams but also mitigates risks associated with market fluctuations in single sectors. The company's real estate segment generates consistent cash flow through property sales and rental income, underwriting its forays into the less predictable biotech sector. Meanwhile, investments in technology and biotechnology hold the potential for substantial returns, underpinning growth through innovations that could revolutionize industries. Through strategic investment, development expertise, and market adaptability, Shanghai Wanye Enterprises Co Ltd effectively harnesses various economic waves, positioning itself as a resilient business entity in China's rapidly evolving economic landscape.